DPPC (129Y83) (Synonyms: 1,2-DPPC, 1,2-Dipalmitoyl-sn-glycero-3-Phosphatidylcholine, LDipalmitoyl Lecithin, 16:0/16:0-PC, PC(16:0/16:0))

Name: DPPC (129Y83)
Brand: GlpBio
SKU: GC33629
Availability: InStock
Rating: 5 (20 reviews)

Catalog No.GC33629

DPPC (129Y83) (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers.

Products are for research use only. Not for human use. We do not sell to patients.

DPPC (129Y83) Chemical Structure

Cas No.: 63-89-8

Size

Price

Stock

Qty

10mg	$56.00	In stock
50mg	$82.00	In stock

Tel：(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 1 publications

Int Immunopharmacol 127 (2024)：111412.PMID:38160567

Description Protocol Chemical Properties Product Documents

Product Documents

Quality Control & SDS

View current batch:

Purity: >95.00%

Protocol

Cell experiment [1]:
Cell lines	Bovine embryos (IVPEs)
Preparation Method	The effect of (DPPC (129Y83)-produced multilamellar vesicles (MLVs) on the lipid profile of the plasma membrane of IVP bovine embryos was also evaluated by matrix-assisted laser desorption/ionisation mass spectrometry (MALDI-MS). The MLVs were prepared by the lipid hydration method. Briefly, a DPPC chloroform solution (10-3 mol/L) was placed in a glass vial, followed by the chloroform evaporation under nitrogen flow. The MLVs were prepared by adding the appropriate aqueous solution to the DPPC film containing vial at 55℃, stirred for 1 h before cooling down to room temperature. MLV stability was investigated by measuring the vesicle size with different media and time intervals. The film was resuspended in ultrapure water and SOFaaci medium in the absence or presence of 2.5% foetal bovine serum (FBS; v/v), 5 mg/mL bovine serum albumin (BSA), and 13 mmol/L pyruvate. For each resuspension medium, three different lipid concentrations were used: 1.0, 1.5, or 2.0 mmol/L. In addition, the MLVs were evaluated immediately after production (refrigerated at 4℃) and after incubation at 38.5℃ in a controlled gas atmosphere (5% O2, 5% CO2, and 90% N2) for 24 and 48 h.
Reaction Conditions	1.0 and 1.5 mmol/L DPPC (129Y83) for 24 h
Applications	The largest MLVs were observed with 1.0 and 1.5 mmol/L DPPC (129Y83) (with or without incubation) in water compared with SOFaaci medium. After 24 h of incubation, MLVs with the largest diameter (approximately 1.5 µm) were obtained with 1.0 mmol/L DPPC (129Y83) in the culture medium.
Animal experiment [2]:
Animal models	Female BALB/c mice (6-wk-old)
Preparation Method	Liposomes for liposome immune lysis assay (LILA) were prepared from a lipid mixture solution containing DMPC (0.5 μmol), Chol (0.5 μmol), DPPA (0.05 μmol) and GSLs (0.05 μmol) and used for detection of anti-GSL antibodies.Mice was intraperitoneally immunized as follows: group I, GSL alone (0.05 μmol); group II, liposome composed of DMPC, Chol , S. minnesota R595 LPS and GSL; group III, liposome composed of DPPC (129Y83) (0.5 μmol), Chol , S. minnesota R595 LPS and GSL (DPPC (129Y83)-liposome); group IV, liposome composed of DSPC, Chol, and S. minnesota R595 LPS and GSL. All were immunized with 0.5 ml of the immunogen per mouse.
Dosage form	0.05 μmol DPPC (129Y83)
Applications	DPPC (129Y83)-liposome would serve effectively as a delivery vehicle for inducing immune responses against GSL antigen.
References: [1]. De Rossi H, Bortoliero Costa C, et,al. Modulating the lipid profile of blastocyst cell membrane with DPPC multilamellar vesicles. Artif Cells Nanomed Biotechnol. 2022 Dec;50(1):158-167. doi: 10.1080/21691401.2022.2088545. PMID: 35713365. [2]. Uemura A, Watarai S, et,al.Induction of immune responses against glycosphingolipid antigens: comparison of antibody responses in mice immunized with antigen associated with liposomes prepared from various phospholipids. J Vet Med Sci. 2005 Dec;67(12):1197-201. doi: 10.1292/jvms.67.1197. PMID: 16397376.

DPPC (129Y83) is a phosphoglyceride that can be used in liposome preparation.

When to evaluate the effect of multilamellar vesicles (MLVs) of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC (129Y83)) in co-culture with in vitro-produced bovine embryos (IVPEs). Incubation (24 and 48 h) did not impair the MLV structure but affected the average diameter. The rate of blastocyst production was not reduced, demonstrating the nontoxicity of the MLVs even at 2.0 mmol/L^[1]. The interactions in cholesterol/DPPC (129Y83)/APC films were found to be weaker than those in the cholesterol/DPPC (129Y83) system, serving as a model of healthy cell membranes, thus proving that the incorporation of APCs is, from a thermodynamic point of view, unfavorable for binary cholesterol/DPPC (129Y83) monolayers^[2]. To elucidate the interaction of a cationic surfactant synthesized, investigations involving Nα-benzoyl-arginine decyl amide (Bz-Arg-NHC10), and model membranes composed by 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC (129Y83)) were done. As the concentration of Bz-Arg-NHC10 increased, the main transition temperature of DPPC (129Y83) slightly decreased^[3]. MPOx copolymers are proved to modify both the size and lamellarity of DPPC (129Y83) liposomes. The gradient copolymer with higher hydrophilic content induces shrinkage of the uni- and bi-lamellar DPPC (129Y83) vesicles^[4]. DPPC (129Y83) liposomes enhanced the pulmonary absorption of unencapsulated free insulin;although unencapsulated free insulin spreads throughout the alveolar mucus layer, the concentration of insulin released near the absorption surface is increased by the encapsulation of insulin into DPPC (129Y83) liposomes and the absorption efficiency is also increased^[5]. When show how oppositely charged gold nanoparticles (Au-NPs) interact with monolayers of the zwitterionic DPPC (129Y83). For the zwitterionic DPPC (129Y83), on the other hand, significant effects only occurred for negatively charged NPs, including a decrease in elasticity^[6].

DPPC (129Y83)-liposome would serve effectively as a delivery vehicle for inducing immune responses against GSL antigen^[7].

References:
[1]. De Rossi H, Bortoliero Costa C, et,al. Modulating the lipid profile of blastocyst cell membrane with DPPC multilamellar vesicles. Artif Cells Nanomed Biotechnol. 2022 Dec;50(1):158-167. doi: 10.1080/21691401.2022.2088545. PMID: 35713365.
[2]. Wn?trzak A, L?tka K, et,al. Interactions of alkylphosphocholines with model membranes-the Langmuir monolayer study. J Membr Biol. 2013 Jun;246(6):453-66. doi: 10.1007/s00232-013-9557-4. Epub 2013 May 15. PMID: 23673723; PMCID: PMC3682106.
[3]. Hermet M, Elisa Fait M, et,al. Interaction of cationic surfactants with DPPC membranes: effect of a novel Nα-benzoylated arginine-based compound. Amino Acids. 2021 Apr;53(4):609-619. doi: 10.1007/s00726-021-02964-2. Epub 2021 Mar 12. PMID: 33710434.
[4]. Papagiannopoulos A, Pippa N, et,al. Lamellarity and size distributions in mixed DPPC/amphiphilic poly(2-oxazoline) gradient copolymer vesicles and their temperature response. Chem Phys Lipids. 2021 Jan;234:105008. doi: 10.1016/j.chemphyslip.2020.105008. Epub 2020 Nov 9. PMID: 33181095.
[5]. Chono S, Togami K, et,al. Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary absorption of encapsulated insulin compared with co-administered insulin. Drug Dev Ind Pharm. 2017 Nov;43(11):1892-1898. doi: 10.1080/03639045.2017.1353521. Epub 2017 Jul 24. PMID: 28689439.
[6]. Torrano AA, Pereira ÂS, et,al. Probing the interaction of oppositely charged gold nanoparticles with DPPG and DPPC Langmuir monolayers as cell membrane models. Colloids Surf B Biointerfaces. 2013 Aug 1;108:120-6. doi: 10.1016/j.colsurfb.2013.02.014. Epub 2013 Mar 5. PMID: 23528608.
[7]. Uemura A, Watarai S, et,al.Induction of immune responses against glycosphingolipid antigens: comparison of antibody responses in mice immunized with antigen associated with liposomes prepared from various phospholipids. J Vet Med Sci. 2005 Dec;67(12):1197-201. doi: 10.1292/jvms.67.1197. PMID: 16397376.

Cas No.	63-89-8	SDF
Synonyms	1,2-DPPC, 1,2-Dipalmitoyl-sn-glycero-3-Phosphatidylcholine, LDipalmitoyl Lecithin, 16:0/16:0-PC, PC(16:0/16:0)
Canonical SMILES	CCCCCCCCCCCCCCCC(O[C@H](COC(CCCCCCCCCCCCCCC)=O)COP(OCC[N+](C)(C)C)([O-])=O)=O
Formula	C₄₀H₈₀NO₈P	M.Wt	734.04
Solubility	<30mg/ml in ethanol	Storage	Store at -20°C
General tips	Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition	Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table

Prepare stock solution
		1 mg	5 mg	10 mg
	1 mM	1.3623 mL	6.8116 mL	13.6232 mL
	5 mM	0.2725 mL	1.3623 mL	2.7246 mL
	10 mM	0.1362 mL	0.6812 mL	1.3623 mL

Molarity Calculator
Dilution Calculator

Calculate

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg

Average weight of animals: g

Dosing volume per animal:μL

Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Reviews

Review for DPPC (129Y83)

Average Rating: 5 ★★★★★ (Based on Reviews and 20 reference(s) in Google Scholar.)

5 Star

100%

4 Star

3 Star

2 Star

1 Star

Review for DPPC (129Y83)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

Overall Rating

★

Review Title

Review

Nickname

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

DPPC (129Y83) (Synonyms: 1,2-DPPC, 1,2-Dipalmitoyl-sn-glycero-3-Phosphatidylcholine, LDipalmitoyl Lecithin, 16:0/16:0-PC, PC(16:0/16:0))

Customer Reviews

GlpBio Citations

Bioactive Compounds Premium Provider

Product has been cited by 1 publications

Product Documents

Quality Control & SDS

Protocol

Complete Stock Solution Preparation Table

Molarity Calculator

Dilution Calculator

In vivo Formulation Calculator (Clear solution)

Reviews

DPPC (129Y83) (Synonyms: 1,2-DPPC, 1,2-Dipalmitoyl-sn-glycero-3-Phosphatidylcholine, LDipalmitoyl Lecithin, 16:0/16:0-PC, PC(16:0/16:0))

Customer Reviews

GlpBio Citations

Bioactive Compounds Premium Provider

Product has been cited by 1 publications

Product Documents

Quality Control & SDS

Protocol

Complete Stock Solution Preparation Table

Molarity Calculator

Dilution Calculator

In vivo Formulation Calculator (Clear solution)

Related Products

Reviews